Across TCGA pan-cancer cohorts, RNF217-AS1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated RNF217-AS1 data layer compared with 20 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNF217-AS1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RNF217-AS1 expression acts as an unfavorable survival marker.
UCEC and SKCM are the cancer types where RNF217-AS1 Mutation most reproducibly stratifies survival.